| Symbol | XGN |
|---|---|
| Name | EXAGEN INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical Specialities |
| Address | 1261 LIBERTY WAY,SUITE C, VISTA, California, 92081, United States |
| Telephone | +1 760 560-1501 |
| Fax | — |
| — | |
| Website | https://www.exagen.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001274737 |
| Description | Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Additional info from NASDAQ: |
New Form 4/A - EXAGEN INC. <b>Filed:</b> 2026-08-24 <b>AccNo:</b> 0001289625-26-000005 <b>Size:</b> 6 KB
Read moreDirector Robertson Bruce C 🟢 acquired 37.5K shares (1 derivative) of EXAGEN INC. (XGN) at $4.31 Transaction Date: Jun 09, 2026 | Filing ID: 000056
Read moreDirector Kim Paul 🟢 acquired 37.5K shares (1 derivative) of EXAGEN INC. (XGN) at $4.31 Transaction Date: Jun 09, 2026 | Filing ID: 000054
Read moreDirector KAHN SCOTT D 🟢 acquired 37.5K shares (1 derivative) of EXAGEN INC. (XGN) at $4.31 Transaction Date: Jun 09, 2026 | Filing ID: 000043
Read moreDirector McKhann Chas 🟢 acquired 37.5K shares (1 derivative) of EXAGEN INC. (XGN) at $4.31 Transaction Date: Jun 09, 2026 | Filing ID: 000038
Read moreDirector Stokes Frank 🟢 acquired 37.5K shares (1 derivative) of EXAGEN INC. (XGN) at $4.31 Transaction Date: Jun 09, 2026 | Filing ID: 000007
Read more